D. Boral ARC Acquisition I (BCAR)
Formed to complete a business combination, with Exascale Labs as its approved target.
$4.72
At close0.00 (0.00%)
In millions of USD, except per-share figures
| In millions | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 1 | 1 | |
| Selling, general & administrative | 0 | 0 | 0 | 0 | 0 | 0 |
| Other expenses | 0 | 0 | 0 | 0 | 1 | 1 |
| Operating income | 0 | 0 | 0 | 0 | −1 | −1 |
| 0 | 0 | 2 | 3 | 3 | 3 | |
| Interest income | 0 | 0 | 2 | 3 | 3 | 3 |
| Income before tax | 0 | 0 | 2 | 3 | 2 | 2 |
| Net income from continuing operations | 0 | 0 | 2 | 3 | 2 | 2 |
| Net income | 0 | 0 | 2 | 3 | 2 | 2 |
| EPS, basic | −$0.00 | −$0.00 | $0.06 | $0.06 | $0.05 | $0.05 |
| EPS, diluted | −$0.00 | −$0.00 | $0.06 | $0.06 | $0.05 | $0.05 |
| Weighted average shares, basic | 37 | 37 | 31 | 41 | 29 | 29 |
| Weighted average shares, diluted | 37 | 37 | 31 | 41 | 29 | 29 |
| EBITDA | 0 | 0 | 0 | 0 | −1 | −1 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | 0 | 0 | 0 | 0 | −1 | −1 |